Rajendra Singh

机构：Teva Pharmaceuticals (United States)

发表论文 2 篇 · 总被引 12 次 · h-index 2

代表论文

• Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial (2026 · ˜The œLancet. Gastroenterology & hepatology · 被引 6)
• Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial (2026 · ˜The œLancet. Gastroenterology & hepatology · 被引 6)